I G Schmidt-Wolf

Use of a SCID mouse/human lymphoma model to evaluate cytokine-induced killer cells with potent antitumor cell activity.

I G Schmidt-Wolf, RS Negrin, Hans‐Peter Kiem et al. · The Journal of Experimental Medicine · 1991 · 620 citations · Full text

Life Sciences, Immunology, Oncology +17

A randomised, prospective, multicenter, phase III trial of gemcitabine, 5-fluorouracil (5-FU), folinic acid vs. gemcitabine alone in patients with advanced pancreatic cancer

Hanno Riess, A. Helm, Marco Niedergethmann et al. · Journal of Clinical Oncology · 2005 · 102 citations

Medicine, Oncology, Pharmacotherapy +14

FasL is more frequently expressed in liver metastases of colorectal cancer than in matched primary carcinomas

B. Mann, Alexei Gratchev, Christian Böhm et al. · British Journal of Cancer · 1999 · 82 citations · Full text

Medicine, Immunology, Oncology +17

MTX-induced white matter changes are associated with polymorphisms of methionine metabolism

Michael Linnebank, Hendrik Pels, N Kleczar et al. · Neurology · 2005 · 76 citations

Medicine, Neuroscience, Pharmacology +14

Enhanced lytic activity of cytokine-induced killer cells against multiple myeloma cells after co-culture with idiotype-pulsed dendritic cells.

Angela Märten, Sabine Renoth, M von Lilienfeld-Toal et al. · PubMed · 2001 · 70 citations

Life Sciences, Cell Biology, Immunology +17